Stifel Reiterates Hold Rating on Revvity Inc (RVTY)

Stifel analyst Daniel Arias reiterated a Hold rating and $120.00 price target on Revvity Inc (NYSE: RVTY).

The analyst commented, “RVTY's Life Science business appears to have turned the corner toward a recovery - but is still working its way back. 1Q expectations are above peers (those who have guided so far, at least) as RVTY enters the year coming off a return to growth in the pharma/biotech end market, the Applied Genomics segment, and in China."

Also, "Looking ahead, mgmt has assumed no real improvement in conditions, so the case for upside rests with the company benefiting from better end markets amidst expectations that should prove at least somewhat conservative. With valuation at the lower end of the group's range, RVTY could be interesting from here if it looks as though 5% organic is looking more likely than 3%.”

For an analyst ratings summary and ratings history on Revvity Inc click here. For more ratings news on Revvity Inc click here.

Shares of Revvity Inc closed at $126.13 yesterday.

You May Also Be Interested In

• SpaceX Shares Indicated To Open At $155
• Planet Labs (PL) June 50 calls active, share price down 6%
• Increasing unusual put volume: OMER TRIP SPCE PURR BIRK XP